Sargent Investment Group, LLC Cytosorbents Corp Transaction History
Sargent Investment Group, LLC
- $620 Million
- Q1 2025
A detailed history of Sargent Investment Group, LLC transactions in Cytosorbents Corp stock. As of the latest transaction made, Sargent Investment Group, LLC holds 823,500 shares of CTSO stock, worth $872,910. This represents 0.13% of its overall portfolio holdings.
Number of Shares
823,500
Previous 1,248,863
34.06%
Holding current value
$872,910
Previous $1.12 Million
26.71%
% of portfolio
0.13%
Previous 0.18%
Shares
27 transactions
Others Institutions Holding CTSO
# of Institutions
56Shares Held
17.2MCall Options Held
8.1KPut Options Held
6.9K-
Avenir Corp Washington, DC5.04MShares$5.35 Million0.55% of portfolio
-
Skylands Capital, LLC3MShares$3.18 Million0.48% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$2.07 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.68MShares$1.78 Million0.0% of portfolio
-
Cm Management, LLC954KShares$1.01 Million1.04% of portfolio
About Cytosorbents Corp
- Ticker CTSO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 43,577,400
- Market Cap $46.2M
- Description
- Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...